Evidence generation in precision oncology

In this video Rodrigo Dienstmann and Fernanda Mosele discuss the evidence generation in precision oncology from the aspects of clinical trials design and endpoints to assess the impact/value of precision oncology drugs and about room for real-world evidence generation in the regulatory approval of precision oncology therapeutics. Produced by the European Society for Medical Oncology https://www.esmo.org

Video Lainnya